HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Secondary pulmonary hypoplasia — Clinical Guidelines

Overview

Secondary pulmonary hypoplasia refers to underdeveloped lungs often associated with congenital anomalies or intrauterine conditions such as preterm rupture of membranes (PROM) and congenital diaphragmatic hernia (CDH), leading to respiratory compromise and potential neonatal mortality 1 2 3.

Diagnosis

Key Diagnostic Criteria:

- Low lung volume index (LVI) on chest X-ray 3 - Elevated ventilatory index (VI) and low ventilatory efficiency index (VEI) 3 - Hypoplastic lung morphology with normal lobation histologically 2

Recommended Tests:

- Two-dimensional (2D) and three-dimensional (3D) ultrasonography for prenatal assessment 1 - Chest X-ray to evaluate lung volume and structure postnatally 3

Grading:

- Predictive accuracy varies based on underlying condition and severity 1

Management

First-Line Treatments:

- Mechanical ventilation support tailored to respiratory parameters 3 - Artificial surfactant therapy to improve lung function 3

Adjunctive Treatments:

- No specific drug doses mentioned; supportive care including respiratory support is emphasized 3

Special Populations

Pregnancy:

- Prenatal imaging (2D and 3D-US) can predict pulmonary hypoplasia associated with PROM and CDH 1

Pediatrics:

- Neonates with pulmonary hypoplasia syndrome (PHS) following PROM require close monitoring of respiratory parameters and tailored ventilation strategies 3

Key Recommendations

Utilize 2D and 3D ultrasonography for prenatal assessment of pulmonary hypoplasia, particularly in cases of PROM and CDH, to predict outcomes (Evidence: Moderate 1)

Postnatal management should focus on monitoring lung volume index (LVI) and ventilatory indices to guide respiratory support in neonates with suspected PHS (Evidence: Moderate 3)

Consider the heterogeneity of underlying conditions when interpreting predictive values of imaging modalities, as accuracy can vary significantly (Evidence: Weak 1)

References

1 Gonçalves AN, Correia-Pinto J, Nogueira-Silva C. Imagiological methods for prediction of fetal pulmonary hypoplasia: a systematic review. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2021. link 2 Rodríguez LM, García-García I, Correa-Rivas MS, García-Fragoso L. Pulmonary hypoplasia in Jarcho-Levin syndrome. Puerto Rico health sciences journal 2004. link 3 Suzuki K. Respiratory characteristics of infants with pulmonary hypoplasia syndrome following preterm rupture of membranes: a preliminary study for establishing clinical diagnostic criteria. Early human development 2004. link

Secondary pulmonary hypoplasia